| Date Filed | Type | Description |
| 05/18/2023 |
4
| Hoffmeister David F (Director) has filed a Form 4 on ICU MEDICAL INC/DE|
Txns:
| Exercised 485 options to buy
@ $0
Granted 948 options to buy
@ $0 |
|
| 05/16/2023 |
4
| Hoffmeister David F (Director) has filed a Form 4 on Celanese Corp|
Txns:
| Granted 1,777 shares
@ $98.46, valued at
$175k
|
|
| 01/04/2023 |
4
| Hoffmeister David F (Director) has filed a Form 4 on GLAUKOS Corp|
Txns:
| Granted 1,572 shares
@ $0 |
|
| 09/15/2022 |
4
| Hoffmeister David F (Director) has filed a Form 4 on StepStone Group Inc.|
Txns:
| Granted 6,053 shares
@ $0 |
|
| 06/06/2022 |
4
| Hoffmeister David F (Director) has filed a Form 4 on GLAUKOS Corp|
Txns:
| Granted 4,364 shares
@ $0 |
|
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Hoffmeister David F (Director) has filed a Form 4 on GLAUKOS Corp|
Txns:
| Granted 1,455 shares
@ $0 |
|
| 09/27/2021 |
4
| Hoffmeister David F (Director) has filed a Form 4 on StepStone Group Inc.|
Txns:
| Granted 3,205 shares
@ $0 |
|
| 06/07/2021 |
4
| Hoffmeister David F (Director) has filed a Form 4 on GLAUKOS Corp|
Txns:
| Granted 2,382 shares
@ $0 |
|
| 05/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Hoffmeister David F (Director) has filed a Form 4 on GLAUKOS Corp|
Txns:
| Granted 980 shares
@ $0 |
|
| 12/16/2020 |
4
| Hoffmeister David F (Director) has filed a Form 4 on StepStone Group Inc.|
Txns:
| Granted 2,178 shares
@ $0 |
|
| 09/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/15/2020 |
3
| Hoffmeister David F (Director) has filed a Form 3 on StepStone Group Inc. |
| 06/05/2020 |
4
| Hoffmeister David F (Director) has filed a Form 4 on GLAUKOS Corp|
Txns:
| Granted 3,900 shares
@ $0 |
|
| 05/14/2020 |
4
| Hoffmeister David F (Director) has filed a Form 4 on ICU MEDICAL INC/DE|
Txns:
| Exercised 378 options to buy
@ $0
Granted 468 options to buy
@ $0
Granted 1,438 options to buy
@ $181.99, valued at
$261.7k
|
|
| 05/04/2020 |
4
| Hoffmeister David F (Director) has filed a Form 4 on Celanese Corp|
Txns:
| Granted 1,849 shares
@ $0 |
|
| 01/03/2020 |
4
| Hoffmeister David F (Director) has filed a Form 4 on GLAUKOS Corp|
Txns:
| Granted 1,162 shares
@ $0 |
|
| 05/31/2019 |
4
| Hoffmeister David F (Director) has filed a Form 4 on GLAUKOS Corp|
Txns:
| Granted 2,653 shares
@ $0 |
|
| 05/16/2019 |
4
| Hoffmeister David F (Director) has filed a Form 4 on ICU MEDICAL INC/DE|
Txns:
| Exercised 315 options to buy
@ $0
Granted 378 options to buy
@ $0
Granted 1,253 options to buy
@ $225.27, valued at
$282.3k
|
|
| 04/29/2019 |
4
| Hoffmeister David F (Director) has filed a Form 4 on Celanese Corp|
Txns:
| Granted 1,404 shares
@ $0 |
|
| 01/16/2019 |
4
| Hoffmeister David F (Director) has filed a Form 4 on GLAUKOS Corp|
Txns:
| Granted 1,177 shares
@ $0 |
|
| 06/01/2018 |
4
| Hoffmeister David F (Director) has filed a Form 4 on GLAUKOS Corp|
Txns:
| Granted 4,633 shares
@ $0 |
|
| 05/17/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/24/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/04/2018 |
4
| Hoffmeister David F (Director) has filed a Form 4 on GLAUKOS Corp|
Txns:
| Granted 2,123 shares
@ $0 |
|
| 12/14/2017 |
4
| Hoffmeister David F (Director) has filed a Form 4 on GLAUKOS Corp|
Txns:
| Granted 15,000 options to buy
@ $25.77, valued at
$386.6k
|
|
| 04/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/25/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|